Vanguard PRIMECAP Inv (VPMCX)
172.51
-1.56 (-0.90%)
USD |
Jul 27
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.38% | 77.84B | 0.89% | 6.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -9.629B | 39.22% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | VPMCX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Blend |
| Category Index | Russell 1000 TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Theo Kolokotrones | 36.11 yrs |
| Joel Fried | 32.52 yrs |
| Alfred Mordecai | 21.51 yrs |
| M. Ansari | 13.51 yrs |
| James Marchetti | 6.43 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
99
-9.629B
-24.38B
Category Low
19.11B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of June 30, 2021
Performance Versus Category
As of July 27, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of July 27, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Eli Lilly and Co | 5.04% | 246.53 | 1.21% |
| Microsoft Corp | 3.88% | 287.05 | 0.18% |
| Biogen Inc | 3.60% | 331.18 | -0.83% |
| FedEx Corp | 3.54% | 281.85 | -0.28% |
| Adobe Inc | 3.47% | 622.50 | 0.68% |
| Texas Instruments Inc | 3.43% | 186.38 | 0.68% |
| Amgen Inc | 3.33% | 243.98 | -0.29% |
| Micron Technology Inc | 3.26% | 75.46 | 1.67% |
| Alibaba Group Holding Ltd ADR | 2.75% | 194.62 | 4.60% |
| Southwest Airlines Co | 2.41% | 51.91 | 1.49% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | Upgrade |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | VPMCX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Blend |
| Category Index | Russell 1000 TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Theo Kolokotrones | 36.11 yrs |
| Joel Fried | 32.52 yrs |
| Alfred Mordecai | 21.51 yrs |
| M. Ansari | 13.51 yrs |
| James Marchetti | 6.43 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (7-27-21) | 0.89% |
| 30-Day SEC Yield (7-26-21) | Upgrade |
| 7-Day SEC Yield (11-28-03) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 25.99 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 11/1/1984 |
| Last Annual Report Date | 9/30/2020 |
| Last Prospectus Date | 1/31/2021 |
| Share Classes | |
| VPMAX | Inst |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |